Weight management in idiopathic intracranial hypertension: A role for precision medicine in obesity therapeutics

Abstract

Get full access to this article

View all access options for this article.

References

Banerjee

Phuljhele

Saxena

, et al. Impact of weight reduction on structural and functional parameters of the optic nerve in idiopathic intracranial hypertension. Eur J Ophthalmol 2024; 34: 1594–1599.

Potter

Menon

Mollan

. Risk factors and disease associations in people living with idiopathic intracranial hypertension. Expert Rev Neurother 2024; 24: 681–689.

Mollan

Mitchell

Yiangou

, et al. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology 2022; 99: e1090–e1099.

Mitchell

Lyons

Walker

, et al. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain 2023; 146: 1821–1830.

Qin

Yang

, et al. Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: an updated systematic review and meta-analysis including the latest SURMOUNT-2 trial. Endocrine 2024; 86: 70–84.